Triple-negative breast cancer (TNBC) is characterized by a lack of expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2/neu) and exhibits high invasiveness, poor prognosis, and a high recurrence rate [1]. The gene discussed is ESR1; the disease is triple-negative breast carcinoma.